Asthma: Clinical Trials

28 trials for Asthma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 unknown. 28 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 328Unknown 28
Phase 28Unknown 8

Follow Asthma: new trials by email Literature Review of Asthma trials Research Report on Asthma

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma
Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK, Placebo - Asthma
Phase 3UnknownRespirent Pharmaceuticals Co Ltd.4512023-01-302023-03-01
Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma
Flamboyant 125/12, Budesonide/formoterol 200/6, Flamboyant 125/12 Placebo - Asthma
Phase 3UnknownEMS1342022-07-222022-07-27
Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma
Flamboyant 200/12, Budesonide / Formoterol 400/12, Flamboyant 200/12 Placebo - Asthma
Phase 3UnknownEMS1342022-07-222022-07-27
To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial Asthma
Fluticasone propionate Inhalation Aerosol 44 mcg, FLOVENT HFA 44 mcg, Matching Placebo inhaler - Bronchial Asthma
Phase 3UnknownGlenmark Pharmaceuticals Ltd. India7902022-04-152022-05-27
Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics
Magnesium Sulfate, Placebo - Asthma in Children
Phase 2 / Phase 3UnknownOman Medical Speciality Board902020-08-012020-07-13
Efficacy Of Doxophylline As A Sparing Treatment For Inhaled Corticosteroids In Mexican Children With Asthma
Doxophylline, Budesonide - Asthma Chronic, Asthma in Children
Phase 3UnknownUniversidad Autonoma de Nuevo Leon602019-05-012019-03-19
A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50
Test Product, Reference Product, Placebo - Asthma
Phase 3UnknownAmneal Ireland Limited12042018-10-012018-06-20
Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base
Placebo, 90 mcg Reference Product, 180 mcg Reference Product - Asthma
Phase 3UnknownAmneal Ireland Limited1002018-03-162018-06-14
The Effect of Benralizumab on Exercise-induced Bronchoconstriction
Benralizumab - Asthma, Exercise-Induced
Phase 3UnknownLouis-Philippe Boulet402017-12-012017-10-31
Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years
Fluticasone/ Formoterol, fluticasone/ salmeterol - Asthma
Phase 3UnknownMundipharma (China) Pharmaceutical Co. Ltd3302017-06-022019-04-29
Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma
Salmeterol Xinafoate and Fluticasone Propinate Powder, Seretide - Asthma
Phase 3UnknownChia Tai Tianqing Pharmaceutical Group Co., Ltd.3002017-04-012018-03-12
Efficacy of Vitamin D on the Clinical Management of Pediatric Patients With Asthma
GINA treatment fot asthma +vit.D low supplementation dose, GINA treatment fot asthma +vit.D high supplementation dose - Asthma
Phase 3UnknownHospital General Naval de Alta Especialidad - Escuela Medico Naval1002015-11-012015-11-25
Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.
Hi-dose iv MgSO4, Nebulized budesonide, Std-dose iv MgSO4 - Bronchial Asthma
Phase 3UnknownHamad Medical Corporation2402015-06-012024-03-22
IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency
Immune Globulin - Asthma
Phase 3UnknownAjou University School of Medicine302013-12-012016-05-02
Bicentric Prospective Study, Evaluating Bronchial THERMOPLASTY in a Patient Presenting Severe Uncontrolled Asthma
ALAIR, radiofrequency catheter for bronchial THERMOPLASTY - Asthma
Phase 3UnknownAssistance Publique - Hôpitaux de Paris462012-12-012017-11-07
Effect of Aerobic Training in Moderate or Severe Asthmatic Patients
Aerobic training, Breathing exercise - Asthma.
Phase 3UnknownInstituto de Investigação em Imunologia582012-07-012014-01-10
Effects of Montelukast on Airway Regulatory T Cells in Asthma
Montelukast - Asthma
Phase 2 / Phase 3UnknownKurume University152012-06-012013-09-27
Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations
Mepolizumab, Placebo - Asthma, Viral Infection
Phase 3UnknownAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)482012-01-012012-02-07
Study for Asthma Education in Primary Schools
Educational Program, Usual Asthma Information for teachers - Asthma
Phase 3UnknownFundación Pública Andaluza para la gestión de la Investigación en Sevilla45062011-11-012012-06-19
CPASMA: Is There an Improvement in Asthma in Patients With Both Asthma and OSAS Treated With CPAP?
CPAP - Asthma, Obstructive Sleep Apnea Syndrome
Phase 3UnknownCimera1202011-07-012012-06-22

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Inflammation (2)  ·  Lymphoma, Follicular (2)  ·  Status Asthmaticus (2)  ·  Asthma, Exercise-Induced (1)  ·  Bronchial Hyperreactivity (1)  ·  Conjunctivitis, Allergic (1)  ·  Dermatitis, Atopic (1)  ·  Eosinophilia (1)  ·  Food Hypersensitivity (1)  ·  Hypersensitivity (1)  ·  IgG Deficiency (1)  ·  Infections (1)  ·  Lung Diseases, Obstructive (1)  ·  Motor Activity (1)

Broader conditions

Bronchial Diseases (28)  ·  Hypersensitivity, Immediate (28)  ·  Immune System Diseases (28)  ·  Respiratory Hypersensitivity (28)  ·  Respiratory Tract Diseases (28)  ·  Hypersensitivity (27)  ·  Lung Diseases (27)  ·  Lung Diseases, Obstructive (26)  ·  Hemic and Lymphatic Diseases (4)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Hematologic Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)

Interventions

Budesonide (5)  ·  Fluticasone-Salmeterol Drug Combination (4)  ·  montelukast (4)  ·  Fluticasone (2)  ·  Salmeterol Xinafoate (2)  ·  Albuterol (1)  ·  Breathing Exercises (1)  ·  Bronchial Thermoplasty (1)  ·  Immunoglobulins (1)  ·  Magnesium Sulfate (1)  ·  Omalizumab (1)  ·  Saline Solution (1)  ·  benralizumab (1)  ·  doxofylline (1)  ·  fluticasone-formoterol (1)

Sponsors

Amneal Ireland Limited (2)  ·  EMS (2)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Ajou University School of Medicine (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)  ·  Cimera (1)  ·  Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)  ·  Glenmark Pharmaceuticals Ltd. India (1)  ·  Hamad Medical Corporation (1)  ·  Hospital General Naval de Alta Especialidad - Escuela Medico Naval (1)  ·  Instituto de Investigação em Imunologia (1)  ·  King's College London (1)  ·  Kurume University (1)

Countries

Brazil (3)  ·  China (3)  ·  United States (3)  ·  India (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Finland (1)  ·  France (1)  ·  Greece (1)  ·  Japan (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Qatar (1)

Top investigators

Irshad Haque (2)  ·  Alok Nath, MD (1)  ·  Ameet Daftary (1)  ·  Andrew Wilson, MD, MRCP (UK) (1)  ·  Aubier Michel (1)  ·  Christopher Corrigan, MD, PhD (1)  ·  Elisabeth H Bel, MD, PhD (1)  ·  Emmanuelle Dexeus Gabriel Fernandez, pediatrician (1)  ·  Erkki Savilahti, Professor (1)  ·  Iwona Stelmach, Prof. (1)  ·  Jeffrey Blumer, MD (1)  ·  Jeffrey L. Blumer, M.D., Ph.D. (1)  ·  Jose Serrano, MD (1)

Results publications

PMID 36472162, PMID 17356056, PMID 18595980, PMID 19535666, PMID 19726699, PMID 19797480, PMID 19817753, PMID 20420722, PMID 20525652, PMID 20526242, PMID 20538327, PMID 20620566, PMID 20870246, PMID 21315433, PMID 21771118, PMID 21986034, PMID 22093109, PMID 22330698, PMID 22532985, PMID 23595876, PMID 23792089, PMID 24067388, PMID 24447429, PMID 24506910, PMID 24650447, PMID 24698320, PMID 24838406, PMID 24989842, PMID 25277142, PMID 25631639, PMID 25640020, PMID 25643669, PMID 25724847, PMID 25732539, PMID 25749414, PMID 25845986, PMID 25899478, PMID 26019776, PMID 26063507, PMID 27824606, PMID 28298402, PMID 28318759, PMID 29031617, PMID 30326954, PMID 30472801, PMID 34857814, PMID 37438187, PMID 38687061, PMID 42605209, PMID 9727780

NIH funding

2009 (1)